5-90811291-A-G

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1

The NM_032119.4(ADGRV1):​c.16031A>G​(p.Glu5344Gly) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.97 in 1,612,382 control chromosomes in the GnomAD database, including 759,533 homozygotes. In-silico tool predicts a benign outcome for this variant. 14/20 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★). Another nucleotide change resulting in the same amino acid substitution has been previously reported as Likely benign in ClinVar. Synonymous variant affecting the same amino acid position (i.e. E5344E) has been classified as Likely benign.

Frequency

Genomes: 𝑓 0.94 ( 67407 hom., cov: 33)
Exomes 𝑓: 0.97 ( 692126 hom. )

Consequence

ADGRV1
NM_032119.4 missense

Scores

16

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:10

Conservation

PhyloP100: 1.71

Publications

37 publications found
Variant links:
Genes affected
ADGRV1 (HGNC:17416): (adhesion G protein-coupled receptor V1) This gene encodes a member of the G-protein coupled receptor superfamily. The encoded protein contains a 7-transmembrane receptor domain, binds calcium and is expressed in the central nervous system. Mutations in this gene are associated with Usher syndrome 2 and familial febrile seizures. Several alternatively spliced transcripts have been described. [provided by RefSeq, Jul 2008]
ADGRV1 Gene-Disease associations (from GenCC):
  • Usher syndrome type 2
    Inheritance: AR Classification: DEFINITIVE, SUPPORTIVE Submitted by: ClinGen, Orphanet
  • Usher syndrome type 2C
    Inheritance: AR Classification: STRONG Submitted by: G2P, PanelApp Australia, Labcorp Genetics (formerly Invitae)
  • febrile seizures, familial, 4
    Inheritance: AD Classification: LIMITED Submitted by: Ambry Genetics
  • nonsyndromic genetic hearing loss
    Inheritance: AR Classification: NO_KNOWN Submitted by: ClinGen

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=7.7724985E-7).
BP6
Variant 5-90811291-A-G is Benign according to our data. Variant chr5-90811291-A-G is described in ClinVar as Benign. ClinVar VariationId is 46282.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (EAS) allele frequency at 95% confidence interval = 0.977 is higher than 0.05.

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_032119.4. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Selected
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
ADGRV1
NM_032119.4
MANE Select
c.16031A>Gp.Glu5344Gly
missense
Exon 74 of 90NP_115495.3
ADGRV1
NR_003149.2
n.16047A>G
non_coding_transcript_exon
Exon 74 of 90

Ensembl Transcripts

Selected
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
ADGRV1
ENST00000405460.9
TSL:1 MANE Select
c.16031A>Gp.Glu5344Gly
missense
Exon 74 of 90ENSP00000384582.2
ADGRV1
ENST00000638510.1
TSL:1
n.3298A>G
non_coding_transcript_exon
Exon 10 of 26
ADGRV1
ENST00000425867.3
TSL:5
c.4985A>Gp.Glu1662Gly
missense
Exon 22 of 38ENSP00000392618.3

Frequencies

GnomAD3 genomes
AF:
0.939
AC:
142915
AN:
152140
Hom.:
67375
Cov.:
33
show subpopulations
Gnomad AFR
AF:
0.847
Gnomad AMI
AF:
1.00
Gnomad AMR
AF:
0.962
Gnomad ASJ
AF:
0.918
Gnomad EAS
AF:
1.00
Gnomad SAS
AF:
0.993
Gnomad FIN
AF:
0.982
Gnomad MID
AF:
0.949
Gnomad NFE
AF:
0.976
Gnomad OTH
AF:
0.936
GnomAD2 exomes
AF:
0.970
AC:
238719
AN:
246210
AF XY:
0.972
show subpopulations
Gnomad AFR exome
AF:
0.846
Gnomad AMR exome
AF:
0.980
Gnomad ASJ exome
AF:
0.923
Gnomad EAS exome
AF:
1.00
Gnomad FIN exome
AF:
0.981
Gnomad NFE exome
AF:
0.974
Gnomad OTH exome
AF:
0.969
GnomAD4 exome
AF:
0.973
AC:
1421241
AN:
1460124
Hom.:
692126
Cov.:
39
AF XY:
0.974
AC XY:
707375
AN XY:
726148
show subpopulations
African (AFR)
AF:
0.843
AC:
28195
AN:
33436
American (AMR)
AF:
0.977
AC:
43516
AN:
44556
Ashkenazi Jewish (ASJ)
AF:
0.923
AC:
24079
AN:
26076
East Asian (EAS)
AF:
1.00
AC:
39694
AN:
39694
South Asian (SAS)
AF:
0.994
AC:
85183
AN:
85732
European-Finnish (FIN)
AF:
0.982
AC:
52412
AN:
53384
Middle Eastern (MID)
AF:
0.960
AC:
5531
AN:
5760
European-Non Finnish (NFE)
AF:
0.976
AC:
1084415
AN:
1111150
Other (OTH)
AF:
0.965
AC:
58216
AN:
60336
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.470
Heterozygous variant carriers
0
1746
3492
5239
6985
8731
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
21642
43284
64926
86568
108210
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.939
AC:
143001
AN:
152258
Hom.:
67407
Cov.:
33
AF XY:
0.941
AC XY:
70051
AN XY:
74464
show subpopulations
African (AFR)
AF:
0.847
AC:
35146
AN:
41512
American (AMR)
AF:
0.962
AC:
14714
AN:
15290
Ashkenazi Jewish (ASJ)
AF:
0.918
AC:
3184
AN:
3470
East Asian (EAS)
AF:
1.00
AC:
5181
AN:
5182
South Asian (SAS)
AF:
0.993
AC:
4796
AN:
4828
European-Finnish (FIN)
AF:
0.982
AC:
10424
AN:
10618
Middle Eastern (MID)
AF:
0.952
AC:
280
AN:
294
European-Non Finnish (NFE)
AF:
0.976
AC:
66382
AN:
68036
Other (OTH)
AF:
0.937
AC:
1982
AN:
2116
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.504
Heterozygous variant carriers
0
421
843
1264
1686
2107
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
910
1820
2730
3640
4550
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.959
Hom.:
159013
Bravo
AF:
0.932
TwinsUK
AF:
0.971
AC:
3599
ALSPAC
AF:
0.975
AC:
3758
ESP6500AA
AF:
0.854
AC:
3209
ESP6500EA
AF:
0.973
AC:
8017
ExAC
AF:
0.968
AC:
116947
Asia WGS
AF:
0.987
AC:
3433
AN:
3478

ClinVar

Significance: Benign
Submissions summary: Benign:10
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not specified Benign:6
PreventionGenetics, part of Exact Sciences
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

Diagnostic Laboratory, Department of Genetics, University Medical Center Groningen
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

Joint Genome Diagnostic Labs from Nijmegen and Maastricht, Radboudumc and MUMC+
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

Genetic Services Laboratory, University of Chicago
Significance:Likely benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

Feb 02, 2012
Laboratory for Molecular Medicine, Mass General Brigham Personalized Medicine
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

Caucasian frequency = 6466/6644 (ESP data)

Mar 06, 2013
Eurofins Ntd Llc (ga)
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

Usher syndrome type 2C Benign:2
Jan 13, 2018
Illumina Laboratory Services, Illumina
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as benign is not then subjected to further curation. The score for this variant resulted in a classification of benign for this disease.

Aug 10, 2021
Genome-Nilou Lab
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

not provided Benign:2
Feb 03, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

Mar 03, 2015
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.038
BayesDel_addAF
Benign
-0.78
T
BayesDel_noAF
Benign
-0.76
CADD
Benign
17
DANN
Benign
0.24
DEOGEN2
Benign
0.071
T
Eigen
Benign
-0.80
Eigen_PC
Benign
-0.58
FATHMM_MKL
Benign
0.14
N
LIST_S2
Benign
0.036
T
MetaRNN
Benign
7.8e-7
T
MetaSVM
Benign
-0.97
T
PhyloP100
1.7
PrimateAI
Benign
0.33
T
PROVEAN
Benign
1.9
N
REVEL
Benign
0.070
Sift
Benign
1.0
T
Sift4G
Benign
1.0
T
Polyphen
0.0
B
Vest4
0.065
MPC
0.053
ClinPred
0.0024
T
GERP RS
4.6
Varity_R
0.060
gMVP
0.52
Mutation Taster
=96/4
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.020
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs2438374; hg19: chr5-90107108; COSMIC: COSV108245833; COSMIC: COSV108245833; API